ATryn is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Revo Biologics, Inc.. The primary component is Antithrombin Alfa.
Product ID | 42976-121_634fb454-4f7f-4b30-9f89-fd3a122cf074 |
NDC | 42976-121 |
Product Type | Human Prescription Drug |
Proprietary Name | ATryn |
Generic Name | Antithrombin Recombinant |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2009-05-06 |
Marketing Category | BLA / BLA |
Application Number | BLA125284 |
Labeler Name | rEVO Biologics, Inc. |
Substance Name | ANTITHROMBIN ALFA |
Active Ingredient Strength | 1750 [iU]/mL |
Pharm Classes | Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA],Recombinant Antithrombin [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2009-05-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125284 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-05-06 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
ANTITHROMBIN ALFA | 1750 [iU]/1 |
SPL SET ID: | ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
42976-121 | ATryn | Antithrombin Recombinant |
42976-125 | ATryn | Antithrombin Recombinant |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() ATRYN 76184729 2743233 Live/Registered |
REVO BIOLOGICS, INC. 2000-12-20 |